PITX1 as a grading, prognostic and tumor-infiltrating immune cells marker for chondrosarcoma: a public database-based immunoassay and tissue sample analysis
BackgroundChondrosarcoma (CHS) is a rare bone cancer originating from chondrocytes, with high-grade cases associated with high mortality rates. However, the prognostic factors and therapeutic targets for CHS have not been studied.MethodsGraded gene differential analysis was conducted on 97 CHS tissu...
Saved in:
| Main Authors: | Zikun Huang, Dongchen Liu, Ying Zhang, Weiqing Lu, Lan Hu, Jinghao Zhang, Lei Xie, Shubiao Chen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1477649/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alternative lengthening of telomeres confers favorable prognosis in chondrosarcomas
by: Ji-Yong Sung, et al.
Published: (2025-05-01) -
Laryngeal chondrosarcoma (clinical case)
by: D. V. Trubin, et al.
Published: (2024-12-01) -
Management of Chondrosarcoma of the Mandible
by: KRISHNAPPA R, et al.
Published: (2025-08-01) -
Exploring the causal relationship between immune factors and chondrosarcoma: a Mendelian randomization study
by: Taichuan Xu, et al.
Published: (2025-05-01) -
Aggressive Subtypes of Laryngeal Chondrosarcoma and their Clinical Behavior: A Systematic Review
by: Cesare Piazza, et al.
Published: (2025-01-01)